GRANTS. Anders Rosengren, a diabetes researcher at the Institute of Neuroscience and Physiology, is one of the recipients of the ERC Consolidator Grant for his research on type 2 diabetes. The European Research Council is providing him with SEK 20 million for his research, which can eventually result in more patients receiving customized treatment for their unique type of diabetes. As a researcher at University of Gothenburg, Anders Rosengren participates…
Interview with this year’s recipient of the Young Fernström Prize: Marcus Lind
DISTINCTION. Marcus Lind, a chief physician and newly appointed professor, has conducted research that has had a significant impact on several guidelines in diabetes care around the world. By participating in major epidemiological research projects while meeting with patients clinically, he is at the forefront of the translational research method. Now he has been awarded the Young Fernström Prize, which is presented to young, highly promising and successful researchers. Marcus…
How blood sugar levels affect risks in type 1 diabetes
NEW STUDY. A major new study on the association between blood glucose levels and risks of organ impairment in people with type 1 diabetes can make a vital contribution to diabetes care, in the researchers’ view. The Swedish study now published in BMJ (British Medical Journal) covers more than 10,000 adults and children with type 1 diabetes. Using the Swedish Diabetes Register, the researchers have been able to monitor the…
Low adherence to cholesterol-lowering medication also protective in type 2 diabetes
DOCTORAL THESIS. Type 2 diabetes patients’ risk of cardiovascular disease and death decreases if they actually take the cholesterol-lowering drugs as prescribed. However, research shows that the risk is also reduced if they do not take the full dosage. “These results are important and useful for patients and healthcare providers alike, to try and motivate patients to follow the recommended treatment even if they forget to take their pills from…
Gut microbiota products can favor diabetes
NEW STUDY. A study published in the journal Cell shows that the gut microbiota has the ability to affect how cells respond to insulin, and can thus contribute to type 2 diabetes. The findings demonstrate an hereto unknown pathological mechanism. During recent years, the gut microbiota has been associated with health and several disease conditions. However, only a few studies have investigated whether an altered gut microbiota can directly affect…